(Q33979426)

30 July 2017

Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection (English)

1 reference

30 July 2017

Streptococcus pneumoniae

1 reference

inferred from title

Staphylococcus aureus

1 reference

1 reference

J D Knudsen

1

1 reference

30 July 2017

K Fuursted

2

1 reference

30 July 2017

S Raber

3

1 reference

30 July 2017

F Espersen

4

1 reference

30 July 2017

N Frimodt-Moller

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

1 reference

30 July 2017

44

1 reference

30 July 2017

5

1 reference

30 July 2017

1247-1254

1 reference

A critical review of the dosage of teicoplanin in Europe and the USA.

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Teicoplanin pharmacokinetics in pediatric patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Activity of teicoplanin and vancomycin against penicillin-resistant pneumococci.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Serum vancomycin concentrations: reappraisal of their clinical value

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Teicoplanin: 10 years of clinical experience

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Pharmacokinetic optimisation of vancomycin therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

The Escalating Problem of Antimicrobial Resistance in Streptococcus pneumoniae

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89852

Daptomycin versus vancomycin treatment for Staphylococcus aureus bacteremia in a murine model.

29 October 2018

1 reference

12 December 2020

1 reference

12 December 2020

Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus

1 reference

12 December 2020

Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus

1 reference

12 December 2020

Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus

1 reference

12 December 2020

Human serum and plasma increase mouse mortality in Staphylococcus aureus intraperitoneal infection

1 reference

12 December 2020

Some laboratory and clinical experiences with a new antibiotic, vancomycin

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin

1 reference

12 December 2020

Effect of schedule of administration on the therapeutic efficacy of penicillin; importance of the aggregate time penicillin remains at effectively bactericidal levels

1 reference

12 December 2020

10.1128/AAC.44.5.1247-1254.2000

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference